BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 15,730
0.00 (0.00%)
At close: Feb 19, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 133.91 billion as of February 20, 2026. Its market cap has increased by 12.41% in one year.
Market Cap
133.91B
Enterprise Value
83.08B
Revenue
18.82B
Ranking
n/a
PE Ratio
18.54
Stock Price
15,730.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 133.91B, a decrease of -30.63%. That is a compound annual growth rate of -8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 133.91B | -2.53% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TiumBio | 175.63B |
| ViGenCell | 162.97B |
| NovMetaPharma | 146.54B |
| CORESTEMCHEMON | 144.84B |
| TegoScience | 115.86B |
| KoBioLabs | 105.06B |
| IMGT Co.,Ltd. | 104.76B |
| CTCBIO | 100.30B |